Differential effects of HIF2α antagonist and HIF2α silencing in renal cancer and sensitivity to repurposed drugs (BMC Cancer, 2021)

(untitled) - Arnaiz, E; Miar, A; Bridges, E; Prasad, N; Hatch, SB; Ebner, D; Lawrie, CH; Harris, AL